Porosome Protein Modulation via Segmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for targeting porosome-related defects in diseases such as cystic fibrosis, diabetes, and neurological disorders face challenges due to the complexity of porosome structure and function, making it difficult to modulate specific proteins without affecting multiple cellular processes, leading to adverse side effects and inefficiencies in treating secretory defects.
Innovation Solution
The development of methods to identify and modulate porosome protein interactions using high-throughput chemical screening and in silico techniques, combined with the use of small molecules and humanized nanobodies, to target specific porosome proteins and restore porosome function, including the reconstitution of functional porosome complexes in live cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to target porosome-related defects, then treatment can be administered, but multiple cellular processes are affected leading to adverse side effects
Solution Approach 1:
The invention segments the porosome complex into individual targetable proteins (e.g., V-ATPase, CFTR, SNAP-25) and develops specific modulators for each component rather than targeting the entire complex non-specifically. This allows precise intervention at the molecular level, treating the underlying defect without disrupting other cellular processes that would cause side effects.
Solution Approach 2:
The invention applies local quality by designing modulators that specifically bind to and modify the function of particular porosome proteins at their precise location within the complex. For example, V-ATPase activators specifically enhance proton pump activity in the porosome without affecting other ATPases in the cell, thereby treating secretory defects while maintaining local specificity and avoiding systemic side effects.
2Ease of operation
If single protein targeting is used, then specific defects can be addressed, but the complexity of porosome structure makes it difficult to modulate without affecting multiple cellular processes
Solution Approach 1:
The invention simplifies the complexity of the porosome structure by segmenting it into discrete, addressable protein components. Each component (V-ATPase, CFTR, SNAP-25, etc.) can be independently targeted with specific modulators, transforming an intractable complex structure into manageable, individually modifiable units that are easier to operate on therapeutically.
Solution Approach 2:
The invention introduces small molecule modulators and nanobodies as intermediaries between the therapeutic goal and the complex porosome structure. These intermediaries specifically bind to target proteins within the porosome complex, mediating the therapeutic effect while shielding the complexity of the overall structure from direct intervention, thereby simplifying the operational approach.
3Reliability
If porosome function is modulated, then secretory defects can be treated, but the coupling of multiple proteins makes specific targeting inefficient
Solution Approach 1:
The invention segments the porosome complex into individual targetable proteins and develops specific modulators for each component rather than targeting the entire complex non-specifically. This allows precise intervention at the molecular level, treating the underlying defect without disrupting other cellular processes that would cause side effects.
Solution Approach 2:
The invention changes the parameters of targetability by identifying specific binding sites, conformational states, and functional parameters of individual porosome proteins that can be selectively modulated. For example, small molecules are designed to bind to specific conformational states of CFTR or V-ATPase, changing the functional parameter of protein interaction specificity, thereby enabling efficient and selective targeting despite the complex coupling of proteins in the porosome assembly.
Data Source
AI summary
The porosome is the main secretory structure of the eukaryotic cell. Presented herein are compositions and methods for the control and regulation of the porosome structure. Including a method of porosome-associated-protein and interacting small molecule identification; usage of small molecules targeted to one or more porosome proteins; compositions and usages of nanobodies coupled with small molecules; the reconstitution of porosomes; and the creation and usage of artificial porosome structures.